ClariCore™ Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy

NAUnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

June 30, 2020

Conditions
Prostate Cancer
Interventions
DEVICE

ClariCore System

Biopsy tissue and correlative spectral data will be acquired using the ClariCore System during a patient's already scheduled radical retropubic prostatectomy (RRP) surgery.

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

21287

Brady Urological Institute, Johns Hopkins Hospital, Baltimore

Sponsors
All Listed Sponsors
lead

Precision Biopsy, Inc.

INDUSTRY

NCT02773940 - ClariCore™ Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy | Biotech Hunter | Biotech Hunter